Spyre Therapeutics, Inc. (SYRE): EPS (Diluted)

Annual figures by period end, from SEC filings.

Stock splits: 1-for-25, first reflected in a filing dated 2023-11-09. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Older than the company's other figures. The latest EPS (Diluted) is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$13.76
Year ended 2023-12-31
2020-12-31: -$1.522021-12-31: -$25.022022-12-31: -$24.862023-12-31: $13.76$13.76
2020-12-31 EPS (Diluted) (USD per share) 2023-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedEPS (Diluted)Change YoYSource filing
2023-12-31$13.76n/m2024-11-18, From 2023-01-01
2022-12-31-$24.86n/m2024-02-29, From 2022-01-01
2021-12-31-$25.02n/c2024-02-29, From 2021-01-01
2020-12-31-$1.52n/a2023-03-02, From 2020-01-01